S
Zodix
Study
Academic Library
Search
Shelves
Open access
Sign in
Search or jump to…
⌘K
Ulrich Storz · Study
Home
/
Author
Ulrich Storz
11 works
· latest 2022
· 1 institutions
cluster: provisional
ORCID 0000-0002-9565-9857
Follow
Suggest an ORCID correction
h-index
8
i10
6
Citations
224
Works here
11
10
11
12
15
16
17
21
22
Most cited in this library
Intellectual property protection
2011 · 117 citations
Antibody-drug conjugates: Intellectual property considerations
2015 · 18 citations
The patent maze of COVID 19 vaccines
2021 · 15 citations
Of patents and patent disputes: The TNFα patent files. Part 1: Humira
2016 · 14 citations
The COVID-19 vaccine patent race
2022 · 12 citations
Works
11 shown
The COVID-19 vaccine patent race
Nature Biotechnology
·
2022
·
1 author
·
Open access
12
citations
The patent maze of COVID 19 vaccines
Expert Opinion on Therapeutic Patents
·
2021
·
1 author
·
review
15
citations
CRISPR Cas9 − Licensing the unlicensable
Journal of Biotechnology
·
2017
·
1 author
·
Open access
10
citations
An update on obtaining and enforcing therapeutic antibody patent claims
Nature Biotechnology
·
2016
·
3 authors
9
citations
Of patents and patent disputes: The TNFα patent files. Part 1: Humira
Human Antibodies
·
2016
·
1 author
14
citations
Antibody-drug conjugates: Intellectual property considerations
mAbs
·
2015
·
1 author
·
Open access
18
citations
IP Issues of Therapeutic Antibodies
SpringerBriefs in biotech patents
·
2012
·
3 authors
·
chapter
9
citations
Biopatent Law: Patent Strategies and Patent Management
SpringerBriefs in biotech patents
·
2012
·
3 authors
·
book
7
citations
International intellectual property strategies for therapeutic antibodies
mAbs
·
2011
·
1 author
·
Open access
6
citations
Intellectual property protection
mAbs
·
2011
·
1 author
·
Open access
117
citations
IP Issues in the Therapeutic Antibody Industry
Springer eBooks
·
2010
·
1 author
·
chapter
7
citations